Home>Topics>Stocks>Roche Holding AG

Roche Holding AG

  1. All
  2. Stock Reports
  3. Fund Reports
  4. Headlines
  1. Roche's rheumatoid arthritis drug wins EU approval for extended use

    Headlines

    Mon, 8 Sep 2014

    ZURICH, Sept 8 (Reuters) - Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis.

  2. InterMune drug may offer big upside to Roche if aimed at liver

    Headlines

    Wed, 27 Aug 2014

    (Reuters) - Roche Holding AG 's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.

  3. Roche to buy U.S. biotech firm InterMune for $8.3 billion

    Headlines

    Mon, 25 Aug 2014

    LONDON/ZURICH (Reuters) - Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment of rare or incurable diseases.

  4. BRIEF-Roche shares rise 0.4 pct after announcing InterMune deal

    Headlines

    Mon, 25 Aug 2014

    Aug 25 (Reuters) - Roche Holding AG : * Shares rise 0.4 percent after announcing purchase of U.S. biotech firm

  5. Roche to buy U.S. biotech firm InterMune for $8.3 billion

    Headlines

    Sun, 24 Aug 2014

    LONDON/ZURICH (Reuters) - Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.

  6. BRIEF-Roche CEO says will continue to do "bolt on" deals

    Headlines

    Sun, 24 Aug 2014

    Aug 24 (Reuters) - Roche Holding AG : * CEO declines to comment on market rumours when asked about CHUGAI * CEO says from a financial standpoint will be able to digest this acquisition

  7. Roche to buy U.S. biotech firm InterMune for $8.3 bln

    Headlines

    Sun, 24 Aug 2014

    LONDON, Aug 24 (Reuters) - Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating...

  8. Chugai soars on report of talks to become Roche's 100 pct unit

    Headlines

    Sun, 17 Aug 2014

    TOKYO, Aug 18 (Reuters) - Chugai Pharmaceutical Co Ltd shares rose 21 percent to a record high following a media report that Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese firm that it doesn't already own for about $10 billion.

  9. Chugai denies talks with Roche regarding a takeover

    Headlines

    Sat, 16 Aug 2014

    TOKYO, Aug 17 (Reuters) - Chugai Pharmaceutical Co Ltd has denied a media report saying Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese company that it does not...

  10. Roche to offer $10 billion for rest of Chugai: Bloomberg

    Headlines

    Fri, 15 Aug 2014

    (Reuters) - Roche Holding AG is in talks to buy the almost 40 percent stake in Japan's Chugai Pharmaceutical Co Ltd that it does not already own for about $10 billion, Bloomberg reported, citing people familiar with the matter.

« Prev123Next »
Content Partners